CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Over-the-Counter (OTC) Drug Review | OTC Monograph Reform in the CARES Act

RegulatoryNeutral
AI Analysis

Summary

FDA announcement regarding Over-the-Counter Drug Monograph Reform provisions under the CARES Act. No specific drug approvals, clinical data, or company-level information provided in the article.

Importance:2/10
Sentiment:
0.00
OTCMonographCARES ActRegulatory Reform

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 7, 2026 3:57 PM

Read Original